
Mustang Bio, Inc.
USD0.74
-0.02 (-2.64%)
CEO
Manuel Litchman
IPO Date
2017-08-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.76
Prev. Close
$0.76
Day Low
$0.74
Day High
$0.80
52W Low
$0.53
52W High
$7.00
Market Cap
$0.01B
Volume
0.07M
Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted CAR T in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia